Series date: 
10/01/2019 - 7:00am EDT to 12/31/2023 - 8:00am EST

Course Description:

The Gastrointestinal Cancer Multidisciplinary Tumor Board plays a critical role in the spectrum of cancer management of gastrointestinal malignancies, including diagnosis, staging, treatment and palliative care. The multidisciplinary approach has become crucial recently due to the ever-increasing complexity of medical knowledge and the huge wealth of information that is available to physicians, in addition to the complexity of the various medical procedures and interventions available for cancer care.

Target audience: 

Medical oncologists, radiation oncologists, colorectal surgeons, pathologists, gastroenterologists, physician assistants, nurse practitioners, occupational therapists, pharmacists, respiratory therapists, nurses, social workers, radiologic technologists, and all personnel involved in the care of the gastrointestinal cancer patient.

Learning objectives: 

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.


•    Develop a comprehensive treatment plan for gastrointestinal oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 
 

Faculty & Disclosure

Antonio Ucar, M.D. 
Moderator, Gastrointestinal Tumor Board
Hematologist/Oncologist
Baptist Health Medical Group, Baptist,  Doctors, Homestead, Mariners, South Miami, and West Kendall Baptist Hospitals

Horacio Asbun, M.D.  
Moderator, Gastrointestinal Tumor Board
Chief of Hepatobiliary & Pancreatic Surgery
Baptist Health Medical Group, Miami Cancer Institute, Baptist Hospital

Antonio Ucar, M.D., conference director of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Horacio Asbun, M.D., conference director of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.
Cris Alegria, Carol A. Covarrubias and Angelique M. Morris and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

image

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system.

Series location: 
Baptist Hospital
8900 N. Kendall Dr
MCI Boardroom 3W280
Miami, FL 33176
United States

Sessions

Sessionsort descending Date
Gastrointestinal: Hepatobiliary Tumor Board 11/18/2020 - 7:00am to 8:30am EST
Gastrointestinal: Hepatobiliary Tumor Board 09/28/2022 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 07/07/2021 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 05/24/2023 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 04/15/2020 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 02/23/2022 - 7:00am to 8:30am EST
Gastrointestinal: Hepatobiliary Tumor Board 11/25/2020 - 7:00am to 8:30am EST
Gastrointestinal: Hepatobiliary Tumor Board 10/05/2022 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 07/14/2021 - 7:00am to 8:30am EDT
Gastrointestinal: Hepatobiliary Tumor Board 05/31/2023 - 7:00am to 8:30am EDT

Pages